Cargando…
Prevalence of Fabry Disease among Patients with Parkinson's Disease
BACKGROUND: An increased prevalence of Parkinson's disease (PD) disease has been previously reported in subjects with Fabry disease (FD) carrying alpha-galactosidase (GLA) mutations and their first-line relatives. Moreover, decreased alpha-galactosidase A (AGLA) enzymatic activity has been repo...
Autores principales: | Lackova, Alexandra, Beetz, Christian, Oppermann, Sebastian, Bauer, Peter, Pavelekova, Petra, Lorincova, Tatiana, Ostrozovicova, Miriam, Kulcsarova, Kristina, Cobejova, Jana, Cobej, Martin, Levicka, Petra, Liesenerova, Simona, Sendekova, Daniela, Sukovska, Viktoria, Gdovinova, Zuzana, Han, Vladimir, Rizig, Mie, Houlden, Henry, Skorvanek, Matej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803460/ https://www.ncbi.nlm.nih.gov/pubmed/35111290 http://dx.doi.org/10.1155/2022/1014950 |
Ejemplares similares
-
Impact of the COVID-19 outbreak on neurological consultation in an emergency department
por: Maretta, Milan, et al.
Publicado: (2022) -
Variant recurrence confirms the existence of a FBXO31‐related spastic‐dystonic cerebral palsy syndrome
por: Dzinovic, Ivana, et al.
Publicado: (2021) -
Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease
por: Okubadejo, Njideka U., et al.
Publicado: (2018) -
Fabry disease
por: Germain, Dominique P
Publicado: (2010) -
Parkinson’s Disease in Kazakhstan: Clinico-Demographic Description of a Large Cohort
por: Kaiyrzhanov, Rauan, et al.
Publicado: (2020)